<DOC>
	<DOCNO>NCT02592161</DOCNO>
	<brief_summary>A randomize , single center , double blind , parallel , placebo-controlled , clinical study efficacy safety Chung A Won placebo 24 week three time day improvement osteoporosis symptom Women 's old 50 patient osteoporosis .</brief_summary>
	<brief_title>Clinical Study Efficacy Safety Chung A Won Women 's Patients With Osteoporosis</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<criteria>1 ) Female 50 year old osteoporosis 1 . Wash peroid : use agent 3 month osteoporosis 2 . Subject take drug may affect clinical trial ( Corticosteroids , anticonvulsant , tranquilizer , antidepressant , hypnotic , diuretic ) 3 . Subject chronic liver disease , thyroid disease chronic renal disease 4 . Subject chronic alcoholic undernourish 5 . Other condition suitable study : Severe physical defect mental defect 6 . Pregnant woman 7 . Subject calibrate hypercalcemia/hypocalcemia 8 . Secondary osteoporosis : Subject take drug ( Glucocorticoid , Diabetes Medications ) 9 . Subject 60 % fracture risk FRAX ( WHO fracture risk assessment tool )</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>